Skip to Content
Merck
  • Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.

Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.

British journal of pharmacology (2014-05-16)
Teng Jiang, Jin-Tai Yu, Xi-Chen Zhu, Qiao-Quan Zhang, Meng-Shan Tan, Lei Cao, Hui-Fu Wang, Jie Lu, Qing Gao, Ying-Dong Zhang, Lan Tan
ABSTRACT

As a newer component of the renin-angiotensin system, angiotensin-(1-7) [Ang-(1-7) ] has been shown to facilitate angiogenesis and protect against ischaemic damage in peripheral tissues. However, the role of Ang-(1-7) in brain angiogenesis remains unclear. The aim of this study was to investigate whether Ang-(1-7) could promote angiogenesis in brain, thus inducing tolerance against focal cerebral ischaemia. Male Sprague-Dawley rats were i.c.v. infused with Ang-(1-7), A-779 (a Mas receptor antagonist), L-NIO, a specific endothelial NOS (eNOS) inhibitor, endostatin (an anti-angiogenic compound) or vehicle, alone or simultaneously, for 1-4 weeks. Capillary density, endothelial cell proliferation and key components of eNOS pathway in the brain were evaluated. Afterwards, rats were subjected to permanent middle cerebral artery occlusion (pMCAO), and regional cerebral blood flow (rCBF), infarct volume and neurological deficits were measured 24 h later. Infusion of Ang-(1-7) for 4 weeks significantly increased brain capillary density via promoting endothelial cell proliferation, which was accompanied by eNOS activation and up-regulation of NO and VEGF in brain. These effects were abolished by A-779 or L-NIO. More importantly, Ang-(1-7) improved rCBF and decreased infarct volume and neurological deficits after pMCAO, which could be reversed by A-779, L-NIO or endostatin. This is the first evidence that Ang-(1-7) promotes brain angiogenesis via a Mas/eNOS-dependent pathway, which enhances tolerance against subsequent cerebral ischaemia. These findings highlight brain Ang-(1-7)/Mas signalling as a potential target in stroke prevention.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Human VEGF-A ELISA Kit, for serum, plasma, cell culture supernatants and urine
Sigma-Aldrich
Human VEGF R2 ELISA Kit, for serum, plasma, cell culture supernatant and urine
Sigma-Aldrich
Mouse VEGF ELISA Kit, for serum, plasma, cell culture supernatant
Sigma-Aldrich
Mouse VEGF ELISA Kit, for cell and tissue lysates
Sigma-Aldrich
Rat VEGF ELISA Kit, for serum, plasma and cell culture supernatant
Sigma-Aldrich
Rat VEGF ELISA Kit, for cell and tissue lysates
Sigma-Aldrich
Human VEGF ELISA Kit, for cell and tissue lysates
Sigma-Aldrich
Human VEGF R3 ELISA Kit, for serum, plasma, cell culture supernatant, urine